United States · FDA National Drug Code directory

Guaifenesin Extended-Release

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
68094-048_9147ee25-d849-468c-a83d-7b413539c487
Product NDC
68094-048
Form
TABLET, MULTILAYER, EXTENDED RELEASE
Composition / generic term
Guaifenesin
Labeler
Precision Dose Inc.
Marketing category
ANDA
Marketing start / end (source format)
20230322
Source listing expiry
20261231

Source-listed ingredients

  • GUAIFENESIN — 600 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 BLISTER PACK in 1 CARTON (68094-048-61) / 10 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BLISTER PACK (68094-048-59) · 68094-048-61

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Guaifenesin Extended-Release — United States | Molindra Medicines